Integrated BioPharma, Inc. (INBP)
OTCMKTS · Delayed Price · Currency is USD
0.3327
+0.0127 (3.98%)
At close: Jan 30, 2026
Integrated BioPharma Market Cap
Integrated BioPharma has a market cap or net worth of $10.33 million as of January 30, 2026. Its market cap has increased by 50.59% in one year.
Market Cap
10.33M
Enterprise Value
6.36M
Revenue
53.43M
Ranking
n/a
PE Ratio
15.12
Stock Price
$0.33
Market Cap Chart
Since December 22, 1995, Integrated BioPharma's market cap has decreased from 25.02M to 10.33M, a decrease of -58.69%. That is a compound annual growth rate of -2.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 10.33M | -6.27% |
| Dec 31, 2025 | 11.03M | 10.37% |
| Dec 27, 2024 | 9.99M | 35.38% |
| Dec 29, 2023 | 7.38M | -29.98% |
| Dec 30, 2022 | 10.54M | -66.03% |
| Dec 29, 2021 | 31.03M | 41.64% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| DAVIDsTEA | 17.98M |
| Starco Brands | 17.68M |
| Limitless X Holdings | 16.98M |
| China Foods Holdings | 13.45M |
| Hi-Great Group Holding Company | 12.30M |
| GPO Plus | 8.24M |
| Wenyuan Group | 7.76M |
| Glucose Health | 7.10M |